Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Hemolytic anemia in a 26-year-old woman with vomiting and fatigue

Malik Elharram, Vladimir Sapon-Cousineau and Vicky Tagalakis
CMAJ August 27, 2018 190 (34) E1013-E1017; DOI: https://doi.org/10.1503/cmaj.171147
Malik Elharram
Division of General Internal Medicine (Sapon-Cousineau, Tagalakis), Jewish General Hospital; Faculty of Medicine (Sapon-Cousineau, Elharram, Tagalakis), McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Sapon-Cousineau
Division of General Internal Medicine (Sapon-Cousineau, Tagalakis), Jewish General Hospital; Faculty of Medicine (Sapon-Cousineau, Elharram, Tagalakis), McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicky Tagalakis
Division of General Internal Medicine (Sapon-Cousineau, Tagalakis), Jewish General Hospital; Faculty of Medicine (Sapon-Cousineau, Elharram, Tagalakis), McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

A 26-year-old black woman underwent evaluation in the emergency department after two weeks of worsening nausea, vomiting and fatigue. Her medical history included having had malaria at eight years of age, for which she had received treatment in Eritrea. A complete review of systems was unremarkable aside from a two-day history of a mild bitemporal headache. The patient stated no recent changes in her dietary habits or bowel movements. She did not take any medication or over-the-counter products, and she had never used illicit drugs. She had no history of venous thromboembolism.

Our patient’s vital signs were as follows: temperature 36.7°C, heart rate 87 beats/min, blood pressure 105/71 mm Hg, respiratory rate 16 breaths/min and oxygen saturation 100% on room air. She appeared fatigued and showed signs of pallor on her palms and nail beds. A complete neurologic examination that included cranial nerves, gait, reflexes, proprioception and sensation was unremarkable. The rest of the physical examination results were normal, including the absence of hepatosplenomegaly.

Laboratory investigations in the emergency department showed normocytic anemia (mean corpuscular volume [MCV] 89.9 [normal 80–96] fL), with hemoglobin 57 [normal 120–152] g/L, mild thrombocytopenia (platelets 119 [normal 150–400] × 109/L) and normal leukocyte count and differential. A preliminary workup for anemia showed elevated lactate dehydrogenase (> 1800 [normal 110–220] U/L) and mildly elevated total bilirubin (23 [normal 3–17] μmol/L), with a conjugated bilirubin of 6 (normal 0–5) μmol/L. The reticulocyte count was normal (26 [normal 7–31] × 103/L). These results, taken in totality, were consistent with hemolytic anemia. There were no previous laboratory results for comparison.

What further evaluation should this patient undergo?

  1. Fibrinogen level

  2. Coomb test

  3. Peripheral blood smear

  4. Malaria antigen test

  5. All of the above

The answer is (e). All of the above are appropriate diagnostic tests for further workup of a hemolytic anemia for this patient. We excluded disseminated intravascular coagulation on the basis of a normal fibrinogen level and normal coagulation studies. To evaluate for autoimmune hemolytic anemia, we ordered a direct Coomb test, which was negative. This result, combined with a normal total complement test, allowed us to conclude that a diagnosis of autoimmune hemolytic anemia was unlikely. Direct Coomb tests have a sensitivity of 90%–95% and specificity of 99% in diagnosing autoimmune hemolytic anemia.1 We chose to order a rapid malaria antigen test even in the absence of recent travel, given our patient’s medical history. The test was negative. To assess for underlying microangiopathic hemolytic anemia, we requested a peripheral blood smear, which showed polychromatophilia, macro-ovalocytes, hypersegmented neutrophils and large platelets (Figures 1 and 2). In addition, schistocytes and fragmented cells were present (Figure 2).

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Peripheral blood smear from a 26-year-old black woman showing anisocytosis, poikilocytosis, macro-ovalocytes, hypersegmented neutrophils and large platelets.

Figure 2:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2:

Peripheral blood smear from the same patient showing macro-ovalocytes and fragmented cells.

Given the results of the peripheral blood smear, which of the following diagnoses should be considered?

  1. Microangiopathic anemia

  2. Sickle cell crisis

  3. Thalassemia

  4. Paroxysmal nocturnal hemoglobinuria

  5. Cobalamin deficiency

The answer is both (a) and (e). Both microangiopathic anemia and cobalamin (vitamin B12) deficiency should be considered. Although our patient was originally from Sub-Saharan Africa, she had no history of sickle cell crisis and, with an absence of sickled red blood cells on peripheral smear, this diagnosis remained low on our differential. Paroxysmal nocturnal hemoglobinuria was possible given the presence of hemolysis with iron deficiency; however, it was unlikely, given our patient’s negative history for venous and arterial thromboembolism, and the absence of leukopenia. Thalassemia could present with hemolytic anemia; however, our patient’s peripheral smear showed macrocytosis as opposed to microcytic hypochromic anemia, which is classically seen in thalassemia.

The presence of schistocytes and fragmented cells supported a diagnosis of microangiopathic hemolytic anemia. At this point, our differential diagnosis included thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (HUS) given the presence of thrombocytopenia and the findings consistent with microangiopathic hemolytic anemia on the peripheral blood smear. Thrombotic thrombocytopenic purpura was lower on our differential given the absence of other associated features, such as altered mental status, renal failure and fever. However, our patient presented with a bitemporal headache and mild thrombocytopenia, which cautioned us to keep this life-threatening diagnosis in mind. Regarding HUS, the patient did not have any history of food-borne illness, exposure to a contaminated water supply or any preceding episode of diarrhea. Furthermore, she had relatively mild thrombocytopenia without the evidence of acute kidney injury commonly associated with HUS. Box 1 summarizes the differential diagnosis of thrombotic microangiopathy.2

Box 1: Differential diagnosis of primary thrombotic microangiopathy2
DiagnosisCauseClinical presentation
Acquired disorders
Thrombotic thrombocytopenic purpuraAutoantibody inhibition of ADAMTS13 activityDiverse, including weakness, gastrointestinal symptoms, purpura and neurologic symptoms; acute kidney injury is uncommon
Hemolytic uremic syndrome (Shiga toxin–mediated)Enteric infection with Shiga toxin–secreting strain of Escherichia coli or Shigella dysenteriaeMore common in children; presents with acute kidney injury after an episode of diarrhea
Complement-mediatedAutoantibody inhibition of complement factor H activityAcute kidney injury
Drug-mediated (immune reaction)Quinine and possibly other drugs with formation of drug-dependent antibodiesSudden onset of severe systemic symptoms and anuric renal failure
Drug-mediated (non-immune reaction)Multiple mechanismsGradual onset of renal failure over weeks or months
Hereditary disorders
Thrombotic thrombocytopenic purpuraADAMTS13 deficiency (homozygous or compound heterozygous for ADAMST13 mutations)Usually presents in children (also possible in adults); acute kidney injury is uncommon
Complement-mediatedMutations in complement genes causing uncontrolled activation of alternative complement pathwayUsually presents in children (also possible in adults); acute kidney injury is common
Metabolism-mediatedHomozygous mutations in MMACHCUsually presents in children younger than 1 year; 1 case reported in an adult with hypertension and acute kidney injury
Coagulation-mediatedHomozygous mutations in DGKEUsually presents in children younger than 1 year with acute kidney injury
  • * Adapted from George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 2014;371:654–66.

We considered vitamin B12 deficiency in our differential diagnosis given the presence of megaloblastic changes on the peripheral blood smear, including macro-ovalocytes, giant platelets and hypersegmented neutrophils. Furthermore, the inappropriately normal reticulocyte count in the context of severe anemia pointed to underlying bone marrow failure. Vitamin B12 deficiency was subsequently confirmed with a serum level of 62 (normal 140–700) pmol/L. In addition, the patient was found to have concomitant iron deficiency, with a ferritin level of 38 (normal 50–300) μg/L, which could have been the reason for our patient’s normal MCV.

Given the finding of severe vitamin B12 deficiency, we gave our patient vitamin B12 parenterally and folic acid supplementation. We administered 1 unit of packed red blood cells, and her hemoglobin increased to 73 g/L with marked improvement in her symptoms. She was subsequently discharged home with vitamin B12 (1000 μg subcutaneously daily for six weeks, then monthly), folic acid (5 mg orally daily) and iron sulfate (300 mg orally daily).

At six weeks’ follow-up, her symptoms had completely resolved, with normalization of her blood counts (hemoglobin 137 g/L, platelets 279 × 109/L) and no signs of hemolysis (normal lactate dehydrogenase and total bilirubin). Of note, her serum vitamin B12 level normalized, suggesting recovery of her tissue stores.

In the context of the patient’s vitamin B12 deficiency, what additional workup should be done?

  1. Bone marrow aspiration

  2. Hemoglobin electrophoresis

  3. Anti-intrinisc/antiparietal cell antibodies

  4. Genetic testing

  5. Methylmalonic acid and homocysteine levels

The answer is (c), anti-intrinsic/antiparietal cell antibodies. Homocysteine and methylmalonic acid are metabolic intermediates that accumulate in vitamin B12 deficiency, and are typically reserved for cases in which the initial vitamin B12 levels are borderline or inconclusive. Genetic testing should not be performed in this patient, as there is no suspicion for an underlying hereditary hemoglobinopathy. Furthermore, a bone marrow aspirate or biopsy is not appropriate to evaluate vitamin B12 deficiency, as the findings typically do not distinguish these deficiencies from other hematologic disorders. Hemoglobin electrophoresis would be appropriate for a suspicion of sickle cell anemia (b) or thalassemia.

In the context of combined vitamin B12 and iron deficiency, we strongly suspected a gastrointestinal malabsorption disorder. Our patient had no anti-intrinsic factor antibodies, but she did have antiparietal cell antibodies, which suggests but is not diagnostic of pernicious anemia. As part of the workup for her severe vitamin B12 deficiency, she underwent a gastroscopy with biopsies that were consistent with autoimmune atrophic gastritis.

Discussion

Clinical manifestations of vitamin B12 deficiency are often subtle; however, the consequences of this condition can be serious, with the potential of reversible bone marrow failure and demyelinating disease of the nervous system. Existing case reports and case series have reported substantial heterogeneity in the clinical presentation of patients with hemolysis secondary to vitamin B12 deficiency.3–11 In our review of the literature, these patients most commonly presented with fatigue, asthenia, sensory neuropathy or jaundice. A small proportion of patients, however, presented asymptomatically, with evidence of hemolysis noticed incidentally on blood work (Box 2).

Box 2: Case series and reports of vitamin B12 deficiency and hemolysis
StudyNo. of patientsMean or median age, yrMean cobalamin level, pg/mL*Other laboratory valuesPeripheral smearClinical presentation
Acharya et al.43Patient 1: 55
Patient 2: 58
Patient 3: 91
Patient 1: 167
Patient 2: 100
Patient 3: 162
Patient 1: Hg 5.0 g/dL; WBC 3100 mm3; platelets 123 000/mm3; reticulocytes 6.3%; MCV 134 fL; homocysteine 62.4 μmol/L; haptoglobin < 6 mg/dL; LDH 3152 U/L
Patient 2: Hg 7.7 g/dL; WBC 3400/mm3; platelets 99 000/mm3; reticulocytes 6%; MCV 115 fL; homocysteine 88.8 μmol/L; LDH 788 U/L; serum haptoglobin < 7 mg/dL Patient 3: Hg 6.6 g/dL, MCV 146 fL; platelets 97 000/mm3; homocysteine 129.7 μmol/L; haptoglobin < 7 mg/dL
Patient 1: Schistocytes and hypersegmented neutrophils
Patient 2: Macrocytosis with anisopoikilocytosis, single hyperpigmented neutrophil/ granulocyte with schistocyte
Patient 3: NR
Patient 1: Lethargy, confusion, exertional dyspnea, difficulty walking, moderate lower extremity edema
Patient 2: Progressively increasing fatigue, bilateral paresthesias, scleral icterus
Patient 3: Increasing fatigue, exertional dyspnea, right upper quadrant pain
Andrès et al.520167 (SD ± 6)Pseudothrombotic microangiopathy: 50Mean hemoglobin 10.3 g/dL; no hematological abnormalities (56 [28%]); pancytopenia 12 (5%); pseudothrombotic microangiopathy 5 (3%); hemolytic anemia 3 (2.5%); positive anti-intrinsic factor antibodies 3 (2.5%)Hypersegmented neutrophils and macrocytosis in two-thirds of patientsAsymptomatic: one-third of patients; mild sensory polyneuropathy or confusion: 92 patients(46%); physical weakness: 40 patients (20%); bilateral edema of the legs: 24 patients (12%); jaundice: 4 patients (2%)
Andrès et al.7677 (range 47–89)52 (normal 12–74)Hemoglobin 68 g/L; platelets 70 × 109/L; homocysteine 16.2 μmol/L; positive anti-intrinsic factor antibodies 4 patients (67%)Megaloblastic anemia and schistocytesAsthenia and dyspnea: 6 patients (100%); jaundice: 5 patients (83%); mild peripheral sensitive neuropathy: 3 patients (50%); impaired mental status: 1 patient (17%); peripheral infiltrated cutaneous purpura: 1 patient (17%)
Chhabra et al.6152116Hemoglobin 4.2 g/dL; platelets 76 × 109/L; MCV 136.8.8 fL; reticulocytes 2.48%; homocysteine > 50 μmol/L; LDH 4050 U/L; haptoglobin < 10 mg/dL; positive anti-intrinsic factor antibodiesMacrocytic dysmorphic red blood cells with slight basophilic stippling, occasional schistocytes with hypersegmented neutrophilsFatigue and chest pain
Garderet et al.8138UndetectableHemoglobin 4.5 g/dL; WBC 2.2 × 103/L; MCV 90 fL; platelets 5 × 103/L; haptoglobin 7 mg/dL; total bilirubin 12 mg/dL; positive anti-intrinsic factor antibodiesHypersegmented neutrophils, anisocytosis, schizocytes, and poikilocytosisAsthenia
Noël et al.9772 (range 43–78)45 μmol/LHemoglobin 42 g/L; platelets 73 × 109/L; reticulocytes 13.1 × 109/L; MCV 110.6 fL; LDH 7310 IU/L; haptoglobin 0.1 g/L; reticulocytes 13.1 × 109/LSchistocytesMild confusion: 2 patients (28.6%)
Kollipara et al.1014259Hemoglobin 6.8 g/dL; WBC 1.3 × 109/L; platelets 112 × 109/L; LDH 1155 U/L; haptoglobin < 10 mg/dL; positive antiparietal cell and anti-intrinsic factor antibodiesNormocytic, normochromic anemia with ovalocytes; tear-shaped red blood cellsAsymptomatic
Prueksaritanond et al.11152< 30Hemoglobin 5.9 g/dL; MCV 87.1 fL; LDH 701 IU/L; platelets 161 × 109/L; WBC 4.7 × 109/L; serum haptoglobin undetectable; homocysteine 100 μmol/L; reticulocyte index 0.4%Marked anisocytosis and poikilocytoisis; tear drop cells, elliptocytes and multiple schistocytesIncreasing generalized fatigue and weakness; jaundice
Yeruva et al.1212260Hemoglobin 4.8 g/dL; platelets 91 000; haptoglobin 2 mg/dL; LDH 1868 IU/L; homocysteine 22.4 μmol/L; positive anti-intrinsic factor; positive antiparietal cell antibodiesMarked anisocytosis, hypochromasia with poikilocytosis, few schistocytesGeneralized fatigue and new onset dyspnea on exertion; pale conjunctiva with icteric sclera
  • Note: LDH = lactate dehydrogenase, MCV = mean corpuscular volume, NR = not recorded, SD = standard deviation, WBC = white blood cells.

  • ↵* Unless otherwise specified.

In the largest study involving patients with documented vitamin B12 deficiency, Andrès and colleagues examined hematologic findings in 201 consecutive patients.4 The results showed that less than half of patients presenting with vitamin B12 deficiency had the classical hematologic features of macrocytosis and hypersegmented neutrophils on peripheral blood smear. Nearly one-third of patients presented without any hematologic findings. Life-threatening hematologic findings including symptomatic pancytopenia, pseudothrombotic microangiopathy and hemolytic anemia were found in about 10% of patients.4 Other studies in the literature have reported varying hematologic findings including pancytopenia9 or autoimmune hemolytic anemia with a positive direct Coomb test result.11 Varying blood smear features have been reported, including hypersegmented neutrophils and macrocytosis, schistocytosis, normocytic and normochromic anemia, anisocytosis and poikilocytosis.3–11 In our literature review, patients who presented with hemolysis usually had vitamin B12 levels of less than 100 pg/mL. A few case reports, however, have described hemolysis in patients with vitamin B12 levels between 100 and 200 pg/mL (Box 2).

The presentation of patients with vitamin B12 deficiency can be quite diverse, with varying clinical and hematologic findings that can mimic other illnesses. The peripheral blood smear is an essential first step in investigating the cause of hemolysis, and evidence of megaloblastic changes and schistocytes should direct a physician to suspect vitamin B12 deficiency as the cause of the anemia.

Footnotes

  • Competing interests: Dr. Tagalakis reports personal fees from advisory boards (Sanofi, Pfizer, Bayer, Britsol–Myers Squibb and Servier), personal fees from speakers bureaus (Sanofi, Pfizer, Bristol–Myers Squibb), grants or honoraria from a commercial organization (Sanofi), and participation in a clinical trial within the past two years, outside the submitted work. No other competing interests were declared.

  • This article has been peer reviewed.

  • The authors have obtained patient consent.

  • Contributors: Malik Elharram and Vladimir Sapon-Cousineau contributed equally to the production of the manuscript. Vicky Tagalakis contributed to drafting the manuscript and provided editorial review of the manuscript. All of the authors reviewed the final version to be published and agreed to act as guarantors of the work.

References

  1. ↵
    1. Parker V,
    2. Tormey CA
    . The direct antiglobulin test: indications, interpretation, and pitfalls. Arch Pathol Lab Med 2017;141:305–10.
    OpenUrlCrossRef
  2. ↵
    1. George JN,
    2. Nester CM
    . Syndromes of thrombotic microangiopathy. N Engl J Med 2014;371:654–66.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Stabler SP
    . Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013;368:149–60.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Acharya U,
    2. Gau JT,
    3. Horvath W,
    4. et al
    . Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature. J Hematol Oncol 2008;1:26.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Andrès E,
    2. Affenberger S,
    3. Zimmer J,
    4. et al
    . Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. Clin Lab Haematol 2006;28:50–6.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Chhabra N,
    2. Lee S,
    3. Sakalis EG
    . Cobalamin deficiency causing severe hemolytic anemia: a pernicious presentation. Am J Med 2015;128:e5–6.
    OpenUrlPubMed
  7. ↵
    1. Andrès E,
    2. Affenberger S,
    3. Federici L,
    4. et al
    . Pseudo-thrombotic microangiopathy related to cobalamin deficiency. Am J Med 2006;119:e3.
    OpenUrlPubMed
  8. ↵
    1. Garderet L,
    2. Maury E,
    3. Lagrange M,
    4. et al
    . Schizocytosis in pernicious anemia mimicking thrombotic thrombocytopenic purpura. Am J Med 2003;114:423–5.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Noël N,
    2. Maigné G,
    3. Tertian G,
    4. et al
    . Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency. QJM 2013;106:1017–22.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Kollipara VK,
    2. Brine PL,
    3. Gemmel D,
    4. et al
    . A case of asymptomatic pancytopenia with clinical features of hemolysis as a presentation of pernicious anemia. J Community Hosp Intern Med Perspect 2016;6:32493.
    OpenUrl
  11. ↵
    1. Prueksaritanond S,
    2. Barbaryan A,
    3. Mirrakhimov AE,
    4. et al
    . A puzzle of hemolytic anemia, iron and vitamin B12 deficiencies in a 52-year-old male. Case Rep Hematol 2013;2013:708489.
    OpenUrl
  12. ↵
    1. Yeruva SL,
    2. Manchandani RP,
    3. Oneal P
    . Pernicious anemia with autoimmune hemolytic anemia: a case report and literature review. Case Rep Hematol 2016;2016:7231503.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (34)
CMAJ
Vol. 190, Issue 34
27 Aug 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hemolytic anemia in a 26-year-old woman with vomiting and fatigue
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hemolytic anemia in a 26-year-old woman with vomiting and fatigue
Malik Elharram, Vladimir Sapon-Cousineau, Vicky Tagalakis
CMAJ Aug 2018, 190 (34) E1013-E1017; DOI: 10.1503/cmaj.171147

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Hemolytic anemia in a 26-year-old woman with vomiting and fatigue
Malik Elharram, Vladimir Sapon-Cousineau, Vicky Tagalakis
CMAJ Aug 2018, 190 (34) E1013-E1017; DOI: 10.1503/cmaj.171147
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • What further evaluation should this patient undergo?
    • Given the results of the peripheral blood smear, which of the following diagnoses should be considered?
    • In the context of the patient’s vitamin B12 deficiency, what additional workup should be done?
    • Discussion
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Management of γ-hydroxybutyrate intoxication and withdrawal
  • Tuberculous monoarthritis of the knee joint
  • Vulvar condyloma lata as a first presentation of syphilis
Show more Practice

Similar Articles

Collections

  • Article Types
    • What Is Your Call?
  • Topics
    • Autoimmune disease
    • Hematology & transfusion medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire